Funded by LUNGevity Foundation, A Breath of Hope Foundation, and Partnership for Cures
Jeffrey A. Borgia, PhD
Rush University Medical Center
Chicago
Dr. Borgia has developed a blood test for identifying the presence of metastatic progression in non-small cell lung cancer. His current project allows for revision of the test to improve its accuracy and potentially reach an accuracy rate that will allow it to be useful as a stand-alone staging test.